Market Share of Coronary Artery Disease Therapeutics Industry
The Coronary Artery Disease Therapeutics Market is moderately fragmented and consists of several major players. The competition is driven by the rise in product launches, the rise in partnerships among hospitals and drug developers, and increasing research for the development of novel therapies. Some of the companies which are operating in the market are AstraZeneca Plc, Novartis AG, Pfizer Inc, Bayer AG, Bristol-Myers Squibb Company, Kowa Pharmaceuticals America, Inc., Merck & Co., Inc, Teva Pharmaceutical Industries Ltd, Viatris Inc (Mylan N.V.)
Coronary Artery Disease Therapeutics Market Leaders
-
AstraZeneca Plc
-
Novartis AG
-
Pfizer Inc
-
Bayer AG
-
Kowa Pharmaceuticals America, Inc.
*Disclaimer: Major Players sorted in no particular order
